Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
03/01/2021 03/02/2021 03/03/2021 03/04/2021 03/05/2021 Date
35.93(c) 35.84(c) 35.5(c) 35.97(c) 36.03(c) Last
1 526 596 1 668 416 1 402 094 1 489 104 1 451 463 Volume
+1.38% -0.25% -0.95% +1.32% +0.17% Change
More quotes
Financials
Sales 2020 36 158 M 43 067 M 43 067 M
Net income 2020 1 735 M 2 067 M 2 067 M
Net Debt 2020 23 519 M 28 014 M 28 014 M
P/E ratio 2020 11,4x
Yield 2020 2,23%
Sales 2021 36 834 M 43 873 M 43 873 M
Net income 2021 1 768 M 2 106 M 2 106 M
Net Debt 2021 21 660 M 25 800 M 25 800 M
P/E ratio 2021 11,4x
Yield 2021 2,35%
Capitalization 20 088 M 23 932 M 23 927 M
EV / Sales 2020 1,21x
EV / Sales 2021 1,13x
Nbr of Employees 311 269
Free-Float 72,0%
More Financials
Company
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (49.2%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (31.4%;... 
More about the company
Notations Surperformance© of Fresenius SE & Co. KGaA
Trading Rating : Investor Rating :
More Ratings
All news about FRESENIUS SE & CO. KGAA
03/05PRESS RELEASE  : Nanogate SE: Divestment of Nanogate Medical Systems GmbH
DJ
03/01DGAP-DD  : Fresenius Medical Care AG & Co. KGaA english
DJ
03/01FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Berenberg
MD
02/26PRESS RELEASE  : Nanogate SE: Divestment of Nanogate Kierspe GmbH
DJ
02/26FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Goldman Sachs
MD
02/26FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from JP Morgan
MD
02/26FRESENIUS SE  : JP Morgan gives a Buy rating
MD
02/25FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
02/25FMC FRESENIUS MEDICAL CARE AG & CO K : Independant Research reiterates its Buy r..
MD
02/25DGAP-DD  : Fresenius SE & Co. KGaA english
DJ
02/25DGAP-DD  : Fresenius Medical Care AG & Co. KGaA english
DJ
02/24FRESENIUS  : wins tenth consecutive Potentialpark award for Germany's best onlin..
PU
02/24FRESENIUS SE  : NorldLB keeps its Buy rating
MD
02/24FRESENIUS MEDICAL CARE  : RBC Adjusts Price Target on Fresenius Medical Care to ..
MT
02/24FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reiterates its Neutral rati..
MD
More news
News in other languages on FRESENIUS SE & CO. KGAA
03/05DGAP-NEWS  : Nanogate SE veräußert Nanogate Medical Systems GmbH
03/05OLIVER BÄTE : Allianz-Chef Bäte bekommt zwölf Prozent Gehaltserhöhung
03/05CONTINENTAL IM FOKUS : Neuer Chef muss zahlreiche Probleme lösen
03/05Weniger Covid-19-Patienten - aber nicht mehr freie Intensivbetten
03/04DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 04.03.2021 - 15.15 Uhr
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 45,55 €
Last Close Price 36,03 €
Spread / Highest target 88,7%
Spread / Average Target 26,4%
Spread / Lowest Target -51,0%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Gerd Krick Chairman-Supervisory Board
Jürgen Götz Chief Legal & Compliance Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-4.78%23 932
AIER EYE HOSPITAL GROUP CO., LTD.-16.14%39 848
TOPCHOICE MEDICAL CORPORATION-14.17%11 716
IHH HEALTHCARE-3.09%11 447
RAMSAY HEALTH CARE LIMITED3.30%11 195
BANGKOK DUSIT MEDICAL SERVICES3.37%11 180